July 2019

Publié le 01.07.2019 08:36

  • Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140-A Multitarget Compound for Alzheimer's Disease.
    Singhal M, Merino V, Rosini M, Cavalli A, Kalia YN.
    Mol Pharm. 2019 Aug 5;16(8):3460-3468. doi: 10.1021/acs.molpharmaceut.9b00252

We had six communications at the Controlled Release Society Annual Meeting and Exposition, July 21-24, 2019, Valencia, Spain

  • Investigation of the segmental activity of the MRP3 drug transporter in porcine intestine ex vivo.
    Y. Arnold, Y. N. Kalia.
  • A micelle-based triple antifungal formulation for topical treatment of fungal infections.
    S. Gou, M. Monod, D. Salomon, Y. N. Kalia.
  • Novel methodology to assess bioequivalence of topical products for dermatological indications.
    M. Lapteva, N. Capony, J. Quartier, Y. N. Kalia.
  • Non-invasive iontophoretic delivery of cytochrome c to the posterior segment and determination of its ocular biodistribution.
    S. Messaoudi, L. Gonzalez-Iglesias, Y. N. Kalia.
  • Polymeric micelle formulations for the cutaneous delivery of tacrolimus: influence of copolymer concentration and nature.
    J. Quartier, M. Lapteva, Y. N. Kalia.
  • Fractional laser ablation for the targeted topical delivery of infliximab from cryomilled polymeric microparticles.
    P. F. Sahraoui, M. Singhal, Y. N. Kalia.